[Diagnostic value of anti-mitochondria antibodies]. 1977

J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi

The histological lesions found in patients with hepatic disease and positive anti-mitochondrial antibodies (AMA) by immunofluorescence were compared with those in 10 subjects of the same age and sex with negative AMA. The majority of the patients with positive AMA were suffering from primary biliary cirrhosis, the diagnosis being based upon the histological appearance (Stage 1 of Scheuer's classification: 40%) or the presence of clinical signs of cholestasis with a compatible histological appearance (40%). None of the remaining patients (20%) with positive AMA nor the 10 individuals with negative AMA showed histological signs suggestive of primary biliary cirrhosis. The absence of certain clinico-biological factors, with the exception of Stage 1 histology, gives a high degree of value to a high level of AMA in the diagnostic of PBC.

UI MeSH Term Description Entries
D007565 Jaundice A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction. Icterus,Jaundice, Hemolytic,Hemolytic Jaundice,Hemolytic Jaundices,Jaundices, Hemolytic
D008105 Liver Cirrhosis, Biliary FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes. Biliary Cirrhosis,Biliary Cirrhosis, Primary,Biliary Cirrhosis, Secondary,Cholangitis, Chronic Nonsuppurative Destructive,Liver Cirrhosis, Obstructive,Primary Biliary Cholangitis,Biliary Cirrhosis, Primary, 1,Primary Biliary Cirrhosis,Secondary Biliary Cholangitis,Secondary Biliary Cirrhosis,Biliary Cholangitides, Primary,Biliary Cholangitis, Primary,Biliary Cholangitis, Secondary,Cholangitides, Primary Biliary,Cholangitis, Primary Biliary,Cholangitis, Secondary Biliary,Cirrhosis, Biliary,Cirrhosis, Secondary Biliary,Liver Cirrhoses, Biliary,Obstructive Liver Cirrhosis,Primary Biliary Cholangitides,Secondary Biliary Cholangitides
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females

Related Publications

J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
January 1994, Journal of clinical microbiology,
J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
September 2008, Autoimmunity reviews,
J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
January 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
August 2011, Chemical biology & drug design,
J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
August 2008, Saudi medical journal,
J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
April 2010, Annals of the rheumatic diseases,
J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
January 1968, British medical journal,
J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
November 1967, British medical journal,
J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
July 1967, The Journal of clinical endocrinology and metabolism,
J D Pedreira, and J Guardia, and J M Benet, and C Martin, and R Esteban, and J M Martinez-Vazquez, and R Bacardi
September 1996, Orvosi hetilap,
Copied contents to your clipboard!